Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells

H. Wu, C. C. Franklin, H. D. Kim and J. T. Turner Department of Pharmacology, School of Medicine, University of Missouri-Columbia 65212. Neurotensin receptors have been shown previously to be coupled to polyphosphoinositide turnover and intracellular Ca2+ ([Ca2+]i) mobilization in HT-29 colonic epit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American Journal of Physiology: Cell Physiology 1991-01, Vol.260 (1), p.C35-C42
Hauptverfasser: Wu, H, Franklin, C. C, Kim, H. D, Turner, J. T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page C42
container_issue 1
container_start_page C35
container_title American Journal of Physiology: Cell Physiology
container_volume 260
creator Wu, H
Franklin, C. C
Kim, H. D
Turner, J. T
description H. Wu, C. C. Franklin, H. D. Kim and J. T. Turner Department of Pharmacology, School of Medicine, University of Missouri-Columbia 65212. Neurotensin receptors have been shown previously to be coupled to polyphosphoinositide turnover and intracellular Ca2+ ([Ca2+]i) mobilization in HT-29 colonic epithelial cells (Bozou et al. Biochem. J. 264: 871, 1989; Turner et al. J. Pharmacol. Exp. Ther. 253: 1049, 1990). In this study, neurotensin was found to enhance dramatically the Ba2(+)- and tetraethylammonium chloride-sensitive K(+)-efflux rate (measured with 86Rb+) in the presence of ouabain and bumetanide, with basal efflux increasing 4.5 +/- 0.5-fold with 10 nM neurotensin. The K(+)-efflux rate, which was partially dependent on the extracellular Ca2+ concentration, was also increased by carbachol and ATP, two other [Ca2+]i-mobilizing agonists in HT-29 cells, as well as by the Ca2+ ionophores ionomycin and A23187, suggesting that the efflux was through Ca2(+)-activated K+ channels. Pretreatment of cells with neurotensin, carbachol, or ATP desensitized subsequent neurotensin-stimulated efflux by 82, 57, and 63%, respectively, confirming our previous results which indicated homologous and heterologous desensitization of the neurotensin receptor-signal transduction pathway. Pretreatment of cells with the protein kinase C activators phorbol 12-myristate 13-acetate (PMA) and mezerein did not affect [Ca2+]i mobilization or K+ efflux directly but desensitized neurotensin-stimulated efflux by greater than 80%. Pretreatment (2 h) with PMA also decreased K+ efflux in response to ionomycin by 59%, although ionomycin-induced [Ca2+]i mobilization was not inhibited. Downregulation of protein kinase C by overnight pretreatment with PMA resulted in recovery of ionomycin-stimulated efflux. These results suggest that agonist-stimulated Ca2(+)-activated K+ channels in HT-29 cells are regulated at multiple steps in the signal transduction pathway.
doi_str_mv 10.1152/ajpcell.1991.260.1.c35
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16077363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16077363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-8b23bae0e0a7d0eb4aaa4d8d39104f6b67c0039e527b7a99066637c2b8647bb93</originalsourceid><addsrcrecordid>eNpFkF9r2zAUxcXYaNN2H2FDT3uqPcmypehxhP6DwmC0z-JKvk4UHMu15HX59lNIaJ4unHPvuYcfId85Kzlvqp-wHR32fcm15mUls1o60Xwii2xWBW-k-EwWTEhRSF6LS3IV45YxVldSX5ALrpdKKb0g5g-u5x6SDwMNHXXQOz_vCnDJ_4WELR1DghizRrHr-vkftXs64DyFhEP0A4WhpSFtcKKwxiFFmrXHl6LS9FAv3pAvHfQRv57mNXm9v3tZPRbPvx-eVr-eC1fXLBVLWwkLyJCBahnaGgDqdtkKzVndSSuVY0xobCplFWjNpJRCucouZa2s1eKa_DjmjlN4mzEms_Px0AAGDHM0XDKlMo28KI-LbgoxTtiZcfI7mPaGM3Mga05kzYGsyWQNNyvR5MNvpw-z3WF7PjuizP7t0d_49ebdT2jGzT760If1_iPzHPcf9UuHZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16077363</pqid></control><display><type>article</type><title>Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Wu, H ; Franklin, C. C ; Kim, H. D ; Turner, J. T</creator><creatorcontrib>Wu, H ; Franklin, C. C ; Kim, H. D ; Turner, J. T</creatorcontrib><description>H. Wu, C. C. Franklin, H. D. Kim and J. T. Turner Department of Pharmacology, School of Medicine, University of Missouri-Columbia 65212. Neurotensin receptors have been shown previously to be coupled to polyphosphoinositide turnover and intracellular Ca2+ ([Ca2+]i) mobilization in HT-29 colonic epithelial cells (Bozou et al. Biochem. J. 264: 871, 1989; Turner et al. J. Pharmacol. Exp. Ther. 253: 1049, 1990). In this study, neurotensin was found to enhance dramatically the Ba2(+)- and tetraethylammonium chloride-sensitive K(+)-efflux rate (measured with 86Rb+) in the presence of ouabain and bumetanide, with basal efflux increasing 4.5 +/- 0.5-fold with 10 nM neurotensin. The K(+)-efflux rate, which was partially dependent on the extracellular Ca2+ concentration, was also increased by carbachol and ATP, two other [Ca2+]i-mobilizing agonists in HT-29 cells, as well as by the Ca2+ ionophores ionomycin and A23187, suggesting that the efflux was through Ca2(+)-activated K+ channels. Pretreatment of cells with neurotensin, carbachol, or ATP desensitized subsequent neurotensin-stimulated efflux by 82, 57, and 63%, respectively, confirming our previous results which indicated homologous and heterologous desensitization of the neurotensin receptor-signal transduction pathway. Pretreatment of cells with the protein kinase C activators phorbol 12-myristate 13-acetate (PMA) and mezerein did not affect [Ca2+]i mobilization or K+ efflux directly but desensitized neurotensin-stimulated efflux by greater than 80%. Pretreatment (2 h) with PMA also decreased K+ efflux in response to ionomycin by 59%, although ionomycin-induced [Ca2+]i mobilization was not inhibited. Downregulation of protein kinase C by overnight pretreatment with PMA resulted in recovery of ionomycin-stimulated efflux. These results suggest that agonist-stimulated Ca2(+)-activated K+ channels in HT-29 cells are regulated at multiple steps in the signal transduction pathway.</description><identifier>ISSN: 0363-6143</identifier><identifier>ISSN: 0002-9513</identifier><identifier>EISSN: 1522-1563</identifier><identifier>DOI: 10.1152/ajpcell.1991.260.1.c35</identifier><identifier>PMID: 1987779</identifier><language>eng</language><publisher>United States</publisher><subject>Adenocarcinoma ; Adenosine Triphosphate - pharmacology ; Barium - pharmacology ; calcium ; Calcium - physiology ; Carbachol - pharmacology ; Cell Line ; Colonic Neoplasms ; Humans ; Ionomycin - pharmacology ; Kinetics ; neurotensin ; Neurotensin - pharmacology ; potassium ; Potassium - metabolism ; Potassium Channels - drug effects ; Potassium Channels - physiology ; Rubidium - metabolism ; Tetradecanoylphorbol Acetate - pharmacology ; Tetraethylammonium ; Tetraethylammonium Compounds - pharmacology</subject><ispartof>American Journal of Physiology: Cell Physiology, 1991-01, Vol.260 (1), p.C35-C42</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-8b23bae0e0a7d0eb4aaa4d8d39104f6b67c0039e527b7a99066637c2b8647bb93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1987779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, H</creatorcontrib><creatorcontrib>Franklin, C. C</creatorcontrib><creatorcontrib>Kim, H. D</creatorcontrib><creatorcontrib>Turner, J. T</creatorcontrib><title>Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells</title><title>American Journal of Physiology: Cell Physiology</title><addtitle>Am J Physiol</addtitle><description>H. Wu, C. C. Franklin, H. D. Kim and J. T. Turner Department of Pharmacology, School of Medicine, University of Missouri-Columbia 65212. Neurotensin receptors have been shown previously to be coupled to polyphosphoinositide turnover and intracellular Ca2+ ([Ca2+]i) mobilization in HT-29 colonic epithelial cells (Bozou et al. Biochem. J. 264: 871, 1989; Turner et al. J. Pharmacol. Exp. Ther. 253: 1049, 1990). In this study, neurotensin was found to enhance dramatically the Ba2(+)- and tetraethylammonium chloride-sensitive K(+)-efflux rate (measured with 86Rb+) in the presence of ouabain and bumetanide, with basal efflux increasing 4.5 +/- 0.5-fold with 10 nM neurotensin. The K(+)-efflux rate, which was partially dependent on the extracellular Ca2+ concentration, was also increased by carbachol and ATP, two other [Ca2+]i-mobilizing agonists in HT-29 cells, as well as by the Ca2+ ionophores ionomycin and A23187, suggesting that the efflux was through Ca2(+)-activated K+ channels. Pretreatment of cells with neurotensin, carbachol, or ATP desensitized subsequent neurotensin-stimulated efflux by 82, 57, and 63%, respectively, confirming our previous results which indicated homologous and heterologous desensitization of the neurotensin receptor-signal transduction pathway. Pretreatment of cells with the protein kinase C activators phorbol 12-myristate 13-acetate (PMA) and mezerein did not affect [Ca2+]i mobilization or K+ efflux directly but desensitized neurotensin-stimulated efflux by greater than 80%. Pretreatment (2 h) with PMA also decreased K+ efflux in response to ionomycin by 59%, although ionomycin-induced [Ca2+]i mobilization was not inhibited. Downregulation of protein kinase C by overnight pretreatment with PMA resulted in recovery of ionomycin-stimulated efflux. These results suggest that agonist-stimulated Ca2(+)-activated K+ channels in HT-29 cells are regulated at multiple steps in the signal transduction pathway.</description><subject>Adenocarcinoma</subject><subject>Adenosine Triphosphate - pharmacology</subject><subject>Barium - pharmacology</subject><subject>calcium</subject><subject>Calcium - physiology</subject><subject>Carbachol - pharmacology</subject><subject>Cell Line</subject><subject>Colonic Neoplasms</subject><subject>Humans</subject><subject>Ionomycin - pharmacology</subject><subject>Kinetics</subject><subject>neurotensin</subject><subject>Neurotensin - pharmacology</subject><subject>potassium</subject><subject>Potassium - metabolism</subject><subject>Potassium Channels - drug effects</subject><subject>Potassium Channels - physiology</subject><subject>Rubidium - metabolism</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Tetraethylammonium</subject><subject>Tetraethylammonium Compounds - pharmacology</subject><issn>0363-6143</issn><issn>0002-9513</issn><issn>1522-1563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkF9r2zAUxcXYaNN2H2FDT3uqPcmypehxhP6DwmC0z-JKvk4UHMu15HX59lNIaJ4unHPvuYcfId85Kzlvqp-wHR32fcm15mUls1o60Xwii2xWBW-k-EwWTEhRSF6LS3IV45YxVldSX5ALrpdKKb0g5g-u5x6SDwMNHXXQOz_vCnDJ_4WELR1DghizRrHr-vkftXs64DyFhEP0A4WhpSFtcKKwxiFFmrXHl6LS9FAv3pAvHfQRv57mNXm9v3tZPRbPvx-eVr-eC1fXLBVLWwkLyJCBahnaGgDqdtkKzVndSSuVY0xobCplFWjNpJRCucouZa2s1eKa_DjmjlN4mzEms_Px0AAGDHM0XDKlMo28KI-LbgoxTtiZcfI7mPaGM3Mga05kzYGsyWQNNyvR5MNvpw-z3WF7PjuizP7t0d_49ebdT2jGzT760If1_iPzHPcf9UuHZQ</recordid><startdate>19910101</startdate><enddate>19910101</enddate><creator>Wu, H</creator><creator>Franklin, C. C</creator><creator>Kim, H. D</creator><creator>Turner, J. T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope></search><sort><creationdate>19910101</creationdate><title>Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells</title><author>Wu, H ; Franklin, C. C ; Kim, H. D ; Turner, J. T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-8b23bae0e0a7d0eb4aaa4d8d39104f6b67c0039e527b7a99066637c2b8647bb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adenocarcinoma</topic><topic>Adenosine Triphosphate - pharmacology</topic><topic>Barium - pharmacology</topic><topic>calcium</topic><topic>Calcium - physiology</topic><topic>Carbachol - pharmacology</topic><topic>Cell Line</topic><topic>Colonic Neoplasms</topic><topic>Humans</topic><topic>Ionomycin - pharmacology</topic><topic>Kinetics</topic><topic>neurotensin</topic><topic>Neurotensin - pharmacology</topic><topic>potassium</topic><topic>Potassium - metabolism</topic><topic>Potassium Channels - drug effects</topic><topic>Potassium Channels - physiology</topic><topic>Rubidium - metabolism</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Tetraethylammonium</topic><topic>Tetraethylammonium Compounds - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, H</creatorcontrib><creatorcontrib>Franklin, C. C</creatorcontrib><creatorcontrib>Kim, H. D</creatorcontrib><creatorcontrib>Turner, J. T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American Journal of Physiology: Cell Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, H</au><au>Franklin, C. C</au><au>Kim, H. D</au><au>Turner, J. T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells</atitle><jtitle>American Journal of Physiology: Cell Physiology</jtitle><addtitle>Am J Physiol</addtitle><date>1991-01-01</date><risdate>1991</risdate><volume>260</volume><issue>1</issue><spage>C35</spage><epage>C42</epage><pages>C35-C42</pages><issn>0363-6143</issn><issn>0002-9513</issn><eissn>1522-1563</eissn><abstract>H. Wu, C. C. Franklin, H. D. Kim and J. T. Turner Department of Pharmacology, School of Medicine, University of Missouri-Columbia 65212. Neurotensin receptors have been shown previously to be coupled to polyphosphoinositide turnover and intracellular Ca2+ ([Ca2+]i) mobilization in HT-29 colonic epithelial cells (Bozou et al. Biochem. J. 264: 871, 1989; Turner et al. J. Pharmacol. Exp. Ther. 253: 1049, 1990). In this study, neurotensin was found to enhance dramatically the Ba2(+)- and tetraethylammonium chloride-sensitive K(+)-efflux rate (measured with 86Rb+) in the presence of ouabain and bumetanide, with basal efflux increasing 4.5 +/- 0.5-fold with 10 nM neurotensin. The K(+)-efflux rate, which was partially dependent on the extracellular Ca2+ concentration, was also increased by carbachol and ATP, two other [Ca2+]i-mobilizing agonists in HT-29 cells, as well as by the Ca2+ ionophores ionomycin and A23187, suggesting that the efflux was through Ca2(+)-activated K+ channels. Pretreatment of cells with neurotensin, carbachol, or ATP desensitized subsequent neurotensin-stimulated efflux by 82, 57, and 63%, respectively, confirming our previous results which indicated homologous and heterologous desensitization of the neurotensin receptor-signal transduction pathway. Pretreatment of cells with the protein kinase C activators phorbol 12-myristate 13-acetate (PMA) and mezerein did not affect [Ca2+]i mobilization or K+ efflux directly but desensitized neurotensin-stimulated efflux by greater than 80%. Pretreatment (2 h) with PMA also decreased K+ efflux in response to ionomycin by 59%, although ionomycin-induced [Ca2+]i mobilization was not inhibited. Downregulation of protein kinase C by overnight pretreatment with PMA resulted in recovery of ionomycin-stimulated efflux. These results suggest that agonist-stimulated Ca2(+)-activated K+ channels in HT-29 cells are regulated at multiple steps in the signal transduction pathway.</abstract><cop>United States</cop><pmid>1987779</pmid><doi>10.1152/ajpcell.1991.260.1.c35</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6143
ispartof American Journal of Physiology: Cell Physiology, 1991-01, Vol.260 (1), p.C35-C42
issn 0363-6143
0002-9513
1522-1563
language eng
recordid cdi_proquest_miscellaneous_16077363
source MEDLINE; Alma/SFX Local Collection
subjects Adenocarcinoma
Adenosine Triphosphate - pharmacology
Barium - pharmacology
calcium
Calcium - physiology
Carbachol - pharmacology
Cell Line
Colonic Neoplasms
Humans
Ionomycin - pharmacology
Kinetics
neurotensin
Neurotensin - pharmacology
potassium
Potassium - metabolism
Potassium Channels - drug effects
Potassium Channels - physiology
Rubidium - metabolism
Tetradecanoylphorbol Acetate - pharmacology
Tetraethylammonium
Tetraethylammonium Compounds - pharmacology
title Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A34%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20calcium-activated%20potassium%20efflux%20by%20neurotensin%20and%20other%20agents%20in%20HT-29%20cells&rft.jtitle=American%20Journal%20of%20Physiology:%20Cell%20Physiology&rft.au=Wu,%20H&rft.date=1991-01-01&rft.volume=260&rft.issue=1&rft.spage=C35&rft.epage=C42&rft.pages=C35-C42&rft.issn=0363-6143&rft.eissn=1522-1563&rft_id=info:doi/10.1152/ajpcell.1991.260.1.c35&rft_dat=%3Cproquest_cross%3E16077363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16077363&rft_id=info:pmid/1987779&rfr_iscdi=true